Pfizer earnings beat by $0.21, revenue fell short of estimates
NeutralFinancial Markets

Pfizer reported its latest earnings, surpassing expectations by $0.21, which is a positive sign for the company. However, its revenue fell short of estimates, raising some concerns among investors. This mixed performance highlights the challenges Pfizer faces in maintaining growth amidst a competitive pharmaceutical landscape, making it a key point of interest for stakeholders.
— Curated by the World Pulse Now AI Editorial System












